Capital Impact Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-49,644
| Closed | -$931K | – | 247 |
|
|
2016
Q4 | $931K | Hold |
49,644
| – | – | 0.39% | 140 |
|
|
2016
Q3 | $820K | Hold |
49,644
| – | – | 0.35% | 160 |
|
|
2016
Q2 | $667K | Hold |
49,644
| – | – | 0.31% | 188 |
|
|
2016
Q1 | $759K | Buy |
49,644
+27,700
| +126% | +$424K | 0.36% | 183 |
|
|
2015
Q4 | $436K | Sell |
21,944
-22,000
| -50% | -$437K | 0.21% | 208 |
|
|
2015
Q3 | $766K | Hold |
43,944
| – | – | 0.39% | 96 |
|
|
2015
Q2 | $889K | Hold |
43,944
| – | – | 0.4% | 93 |
|
|
2015
Q1 | $773K | Buy |
43,944
+34,781
| +380% | +$612K | 0.35% | 119 |
|
|
2014
Q4 | $149K | Hold |
9,163
| – | – | 0.07% | 172 |
|
|
2014
Q3 | $202 | Hold |
9,163
| – | – | ﹤0.01% | 99 |
|
|
2014
Q2 | $184K | Buy |
+9,163
| New | +$184K | 0.14% | 101 |
|